Blocking C-terminal processing of KRAS4b via a direct covalent attack on the CaaX-box cysteine

kisded kisdedUncategorized2 weeks ago26 Views

Proceedings of the National Academy of Sciences, Volume 122, Issue 19, May 2025.
SignificanceThe development of small molecule KRAS inhibitors has proven to be a challenge. Recent clinical development of covalent KRAS G12C inhibitors demonstrates the potential of targeting KRAS oncogenic proteins directly. Compounds that target the …
Read More

0 Votes: 0 Upvotes, 0 Downvotes (0 Points)

Leave a reply

Recent Comments

No comments to show.

Stay Informed With the Latest & Most Important News

I consent to receive newsletter via email. For further information, please review our Privacy Policy

Advertisement

Loading Next Post...
Follow
Sign In/Sign Up Sidebar Search Trending 0 Cart
Popular Now
Loading

Signing-in 3 seconds...

Signing-up 3 seconds...

Cart
Cart updating

ShopYour cart is currently is empty. You could visit our shop and start shopping.